SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹4,735 Cr | ₹-608 Cr | ₹-1,934 Cr | ₹726 Cr | ₹-1,749 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹4,735 Cr |
Mar2023 | ₹-608 Cr |
Mar2022 | ₹-1,934 Cr |
Mar2021 | ₹726 Cr |
Mar2020 | ₹-1,749 Cr |
How is Net Cash Inflow / Outflow of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹4,735 Cr | Positive | |
Mar2023 | ₹-608 Cr | Negative | |
Mar2022 | ₹-1,934 Cr | Negative | |
Mar2021 | ₹726 Cr | Positive | |
Mar2020 | ₹-1,749 Cr | - |
Compare Net Cash Inflow / Outflow of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹405,169.8 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
CIPLA | ₹121,592.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics | |
MANKIND PHARMA | ₹98,309.9 Cr | 1.1% | -7% | 9.7% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -0.3% |
-2.9% |
11.5% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses